Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins

  • Lia M. Haynes
  • , Congrong Miao
  • , Jennifer L. Harcourt
  • , Joel M. Montgomery
  • , Quynh Le Mai
  • , Sergey A. Dryga
  • , Kurt I. Kamrud
  • , Bryan Rivers
  • , Gregory J. Babcock
  • , Jennifer Betts Oliver
  • , James A. Comer
  • , Mary Reynolds
  • , Timothy M. Uyeki
  • , Daniel Bausch
  • , Thomas Ksiazek
  • , William Thomas
  • , Harold Alterson
  • , Jonathan Smith
  • , Donna M. Ambrosino
  • , Larry J. Anderson

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Recombinant severe acute respiratory syndrome (SARS) nucleocapsid and spike protein-based immunoglobulin G immunoassays were developed and evaluated. Our assays demonstrated high sensitivity and specificity to the SARS coronavirus in sera collected from patients as late as 2 years postonset of symptoms. These assays will be useful not only for routine SARS coronavirus diagnostics but also for epidemiological and antibody kinetic studies.

Original languageEnglish (US)
Pages (from-to)331-333
Number of pages3
JournalClinical and Vaccine Immunology
Volume14
Issue number3
DOIs
StatePublished - Mar 2007
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins'. Together they form a unique fingerprint.

Cite this